News
LANXESS India continues to support fight against COVID-19 through its CSR initiatives
LANXESS India has committed over INR 2.1 crores as part of its CSR spends to support the medical infrastructure in the country in its...
Drug Research
Dr. Reddy’s Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India
Dr. Reddy's Laboratories Ltd. announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company ("Lilly") for the...
News
Parexel Achieves Top Rankings in Industry Across Multiple Attributes in ISR CRO Phase II-III Benchmarking Report
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, announced the company has...
Articles
Adding Another Dimension to Protein Analysis
How an emerging mass spectrometry technique – TIMS – is revolutionising shotgun proteomics.
High-performance liquid chromatography with time-of-flight mass spectrometry (HPLC–TOFMS) has become a powerful...
News
MedPharm Expands Its Formulation Development Labs in the UK
MedPharm Ltd, the world leader in formulation and development services for topical and transdermal products, has announced a £1.5M refurbishment that will increase laboratory...
Packaging & Labelling
FedEx Extends Support and Donates Second Charter Flight to Deliver Critical Aid to India
FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, announced the arrival of a second dedicated charter...
Clinical Trials
Bharat Biotechs Covaxin approved for phase 2/3 trials on children
The Drugs Controller General of India (DGCI) has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between two...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read